Table 2.
Clinicopathologic features of THSD7A-immunopositive cases with PLA2R results
| Patient no. | Age/sex | Type of membranous nephropathy | Tissue PLA2R immunofluorescence | Serum anti-PLA2R ELISA |
|---|---|---|---|---|
| 1 | 32/M | Primary | 0 | Negative (12.5 RU/ml) |
| 2 | 50/M | Primary | Positive | Not available |
| 3 | 37/M | Primary | 0 | Positive (111.9 RU/ml) |
| 4 | 49/M | Primary | 0 | Not available |
| 5 | 18/F | Secondary (lupus) | 0 | Negative (not detectable) |
| 6 | 17/F | Primary | 0 | Not available |
ELISA, enzyme-linked immunosorbent assay; F, female; M, male; PLA2R, phospholipase A2 receptor; THSD7A, thrombospondin type 1 domain–containing 7A.